内视镜黏膜下剥离术市场（依产品、手术类型、适应症类型、疾病状况及最终使用者类型）－2025-2030 年全球预测

内视镜黏膜下剥离术市场规模预计在 2024 年达到 4.1294 亿美元，在 2025 年达到 4.366 亿美元，在 2030 年达到 5.8388 亿美元，复合年增长率为 5.94%。

主要市场统计数据
基准年2024年	4.1294亿美元
预计2025年	4.366亿美元
预计2030年	5.8388亿美元
复合年增长率（%）	5.94%

内视镜黏膜下剥离术 (ESD) 是微创胃肠道治疗的突破，最初在东亚地区率先推广，但在西方市场逐渐被接受。此技术能够对黏膜下层的早期肿瘤病变进行整块切除，从而优化组织病理学评估，同时最大限度地降低手术创伤。 ESD 无与伦比的精准度已得到临床界的认可，使其成为治疗早期胃肠道癌症和某些癌前肿瘤的关键。内视镜成像、整合电外科系统和内视镜可操作性等现代技术的进步，显着提高了该手术的安全性，并将其治疗适应症扩展到最初的胃肠道疾病之外。

随着技术的成熟，胃肠外科、肿瘤外科和生物医学工程等跨学科专业知识的整合，推动了器材设计和操作人员能力的不断提升。卓越中心如今已常规整合基于模拟的训练模组、监考系统和结果登记系统，以简化学习曲线并标准化临床通讯协定。这个协作框架加速了ESD的全球应用，使ESD从利基创新发展成为先进治疗性内视镜技术的基石。在此背景下，包括医疗服务、设备製造和报销机构在内的相关人员持续协调，在临床有效性、手术成本控制和患者可及性方面取得平衡。

透过技术创新、培训和以患者为中心的方法揭示内视镜黏膜下剥离术的模式转移

在器械和诊断成像技术不断创新的推动下，内视镜黏膜下剥离术（NES）的领域正在经历模式转移。近期，手术刀技术的改进，例如绝缘尖端、双尖端和三角尖端设计，显着提高了切除精度，同时降低了黏膜下穿孔的风险。同时，高清内视镜视觉化技术与窄带成像和共聚焦雷射内视镜即时组织表征的结合，使临床医生能够以前所未有的精度描绘病变边界。这些技术进步，加上辅助病变分割和电外科参数优化的人工智慧决策支援系统，正在从根本上改变手术的工作流程和疗效。

2025年美国设备采购关税调整及其对临床可近性的影响

2025年，美国针对内视镜黏膜下剥离术（ETS）所需的进口医疗设备及辅助零件实施了一系列关税调整。这些调整给整个供应链带来了微妙的成本压力，尤其对先进的电外科刀、专用充气装置和高解析度内视镜而言。为了减轻到岸成本上升的影响，医院和门诊中心正在评估采购惯例实践的策略转变，包括供应商多元化和积极的合约重新谈判。同时，製造商正在重新评估其供应链配置，探索近岸外包机会，并优化零件采购，以保持竞争性价格，并确保临床医生能够继续使用尖端设备。

依产品技术、治疗方式、临床指征、疾病状态及最终用户通路细分市场

内视镜黏膜下剥离术市场可以透过检视附件设备和核心内视镜系统的产品创新来细分。配件设备包括帽子和罩、钳子和夹、注射器针头、气腹装置、各种刀型以及套管针。就刀类而言，双刀、柔性刀、钩刀、绝缘尖头和三角尖头器械具有独特的性能特点，可根据特定的组织纹理和病变形态进行客製化。内视镜系统进一步细分为大肠镜、十二指肠镜和胃镜，每个系统都体现了独特的人体工学和光学配置，这些配置会影响操作效率和临床医生的偏好。

揭示全球市场的区域采用模式、报销框架与创新轨迹

在美洲，强大的医疗基础设施和完善的报销体系为内视镜黏膜下剥离术的推广奠定了坚实的基础。美国和加拿大的卓越中心在手术量方面处于领先地位，并发表了关键的临床证据，增强了相关人员的信心。支持先进内视镜干预措施的政策环境使支付方能够认识到微创病变切除带来的长期成本节约，从而推动患者获得治疗机会并推动机构对尖端设备的投资。

塑造永续发展教育生态系统的相关人员的竞争格局和策略行动

内视镜黏膜下剥离术 (EMS) 市场的竞争由全球医疗技术领导者和专业创新者主导。现有企业正在透过产品改进、获得先进刀形和人体工学内视镜设计的智慧财产权以及利用全球分销网路渗透市场来增强其产品组合。同时，敏捷的新兴企业正透过引入人工智慧辅助病变检测软体和旨在简化手术流程的下一代气腹技术，获得关注。

积极的策略和协作努力推动创新、市场渗透和永续成长

为了抓住内视镜黏膜下剥离术蓬勃发展的机会，产业领导者必须重视跨职能伙伴关係，以整合临床、监管和商业方面的专业知识。优先投资研发具有自适应回馈机制的下一代电外科手术刀，将有助于实现产品差异化，并应对不断变化的临床挑战。同时，建立一个整合虚拟实境模拟器和认证监考的综合培训生态系统，将确保始终如一的手术质量，并缩短新兴市场的采用曲线。

严谨的多模态研究框架，整合了原始研究、二手资料和分析三角测量

本执行执行摘要所依据的研究严格结合了主要研究方法和次要研究方法。关键意见领袖和内视镜专家参与了结构化访谈和咨询研讨会，以深入观点内视镜黏膜下剥离术的临床工作流程、技术应用障碍和未满足的需求。这些定性见解也辅以对同行评审期刊、临床试验註册中心和会议论文的广泛查阅，以检验不断发展的最佳实践和新兴的设备性能数据。

整合核心洞察与未来发展轨迹，赋能决策者，培养市场领导力

本执行摘要揭示了技术创新、监管变化和市场动态之间复杂的相互作用，这些因素共同塑造了内视镜黏膜下剥离术领域。关键要点强调了先进的手术刀设计、增强的显像模式以及人工智慧决策支援工具对手术有效性和安全性的重大影响。同时，价格调整和不断变化的报销格局的影响需要灵活的筹资策略和积极主动的相关人员参与。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

• 扩展水刀和混合刀技术，以便在 ESD 期间更快、更安全地切除病变
• 将人工智慧驱动的病变识别系统引入内视镜黏膜下剥离术的工作流程
• 开发一种可在ESD手术中同时进行切开和稳定止血的多功能内视镜刀
• 推出一次性内视镜平台，降低黏膜下层剥离过程中交叉污染的风险
• 高解析度 3D 成像和扩增实境迭加集成，可精确定位 ESD 病变
• 基于虚拟实境的ESD培训模拟程序的成长将提高亚太市场医生的熟练程度
• 医疗设备製造商与学术中心伙伴关係，对新型 ESD 牵引装置进行临床检验
• 下一代内视镜注射液获得监管部门核准，可增强黏膜下提升和手术效率
• 使用夹线系统的牵引辅助 ESD 技术的使用增加，从而减少了手术时间和併发症。
• 加强报销政策，支持先进医疗保健系统的门诊治疗

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

8. 内视镜黏膜下剥离术市场（依产品）

• 附属设备
  • 帽子和兜帽
  • 镊子和夹子
  • 针头
  • 吸入装置
  • 刀
    • 双重的
    • 弹性
    • 钩
    • 带绝缘尖端
    • 三角形尖端
  • 套管针
• 内视镜设备
  • 大肠镜检查
  • 十二指肠镜
  • 胃镜

9. 内视镜黏膜下剥离术市场（依手术类型）

• 全层切除术
• 混合 ESD
• 部分厚度切除术

第 10 章内视镜黏膜下剥离术市场（依适应症类型）

• 大肠直肠癌
• 食道癌
• 胃癌

11. 内视镜黏膜下剥离术市场（依疾病状况）

• 良性肿瘤
• 恶性肿瘤
  • 侵入性
  • 非侵入性

第 12 章内视镜黏膜下剥离术市场（依最终使用者类型）

• 门诊手术中心
• 医院
• 专科诊所

13.美洲内视镜黏膜下剥离术市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

14. 欧洲、中东和非洲内视镜黏膜下剥离术市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

15. 亚太地区内视镜黏膜下剥离术市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十六章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Ambu A/S
  • Beijing ZKSK Technology Co., Ltd.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Hoya Corporation
  • Huger Medical Instrument Co., Ltd.
  • Interscope, Inc.
  • Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • Karl Storz SE & Co. KG
  • Leo Medical Co. Ltd.
  • Medi-Globe GmbH by DCC Healthcare
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Mizuho America, Inc.
  • MTW-Endoskopie W. Haag KG
  • Olympus Corporation
  • Ovesco Endoscope AG
  • Richard Wolf GmbH
  • SonoScape Medical Corp.
  • Steris Corporation
  • Zeon Medical Inc.
  • Sumitomo Bakelite Co., Ltd.

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

The Endoscopic Submucosal Dissection Market was valued at USD 412.94 million in 2024 and is projected to grow to USD 436.60 million in 2025, with a CAGR of 5.94%, reaching USD 583.88 million by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 412.94 million
Estimated Year [2025]	USD 436.60 million
Forecast Year [2030]	USD 583.88 million
CAGR (%)	5.94%

Endoscopic Submucosal Dissection (ESD) emerged as a groundbreaking advancement in minimally invasive gastrointestinal interventions, initially pioneered in East Asia and progressively embraced by Western markets. This technique offers the capacity to achieve en bloc resection of early-stage neoplastic lesions within the submucosal layer, thereby minimizing procedural invasiveness while optimizing histopathological assessment. The clinical community has recognized ESD for its unparalleled precision, making it indispensable for managing early gastrointestinal cancers and select premalignant conditions. Contemporary enhancements in endoscopic imaging, electrosurgical system integration, and scope maneuverability have collectively elevated procedural safety profiles and expanded therapeutic indications beyond the initial gastric focus.

As the technology matures, a convergence of multidisciplinary expertise spanning gastroenterology, surgical oncology, and biomedical engineering has driven iterative improvements in instrument design and operator competency. Centers of excellence now routinely incorporate simulation-based training modules, proctorship programs, and outcome registries to streamline learning curves and standardize clinical protocols. These collaborative frameworks have accelerated global adoption, enabling ESD to transition from a niche innovation to a cornerstone in advanced therapeutic endoscopy. Against this backdrop, stakeholders across healthcare delivery, device manufacturing, and reimbursement agencies continue to navigate the balance between clinical efficacy, procedural cost containment, and broadening patient access.

Unveiling the Paradigm Shifts Reshaping Endoscopic Submucosal Dissection Through Innovation, Training, and Patient-Centered Approaches

The landscape of Endoscopic Submucosal Dissection is undergoing a paradigm shift driven by relentless innovation in instrumentation and imaging modalities. Recent refinements in knife technology, including insulation-tipped, dual, and triangle-tipped designs, have significantly enhanced resection precision while mitigating the risk of submucosal perforation. Simultaneously, the integration of high-definition endoscopic visualization and real-time tissue characterization through narrow-band imaging and confocal laser endomicroscopy has empowered clinicians to delineate lesion boundaries with unprecedented accuracy. These technological leaps are complemented by AI-enabled decision support systems that assist in lesion segmentation and electrosurgical parameter optimization, fundamentally altering procedural workflows and outcomes.

Equally transformative are the evolving training paradigms that prioritize competency-based progression and simulation-driven skill acquisition. Virtual reality simulators and ex vivo tissue models now replicate the tactile nuances of tissue dissection, allowing trainees to refine hand-eye coordination and complication management in a risk-free environment. Moreover, cross-institutional mentorship networks and teleproctoring platforms have democratized access to expert guidance, accelerating proficiency in regions previously limited by resource constraints. As a result, procedural adoption curves are flattening, and the global clinician community is advancing toward standardized ESD curricula anchored in rigorous outcome metrics. Collectively, these shifts underscore a patient-centered ethos that prioritizes safety, efficiency, and equitable access as the cornerstones of the next generation of GI therapeutic endoscopy.

Implications of 2025 U.S. Tariff Adjustments on Device Procurement and Clinical Accessibility

In 2025, the United States enacted a series of tariff modifications targeting imported medical devices and accessory components integral to endoscopic submucosal dissection. These adjustments have introduced nuanced cost pressures across the supply chain, particularly for advanced electrosurgical knives, specialized insufflation units, and high-definition endoscopes. Hospitals and outpatient centers are assessing strategic pivots in procurement practices, including supplier diversification and proactive contract renegotiations to mitigate the impact of increased landed costs. Concurrently, manufacturers are reevaluating supply chain configurations, exploring nearshoring opportunities, and optimizing component sourcing to preserve competitive pricing and maintain clinician access to state-of-the-art equipment.

Beyond immediate cost considerations, the tariff landscape is influencing broader research and development priorities. Device innovators are accelerating the design of modular systems that utilize locally sourced components and refining manufacturing processes to reduce dependency on tariff-affected imports. Health systems are likewise undertaking comprehensive budget impact analyses to balance capital expenditures against long-term clinical benefits, with an emphasis on value-based procurement policies. These strategic responses are reshaping the interplay between cost containment and clinical innovation, ultimately defining new benchmarks for market resilience and operational agility in the ESD space.

Deconstructing Market Segmentations Across Product Technologies, Procedure Modalities, Clinical Indications, Pathological Conditions, and End-User Channels

The endoscopic submucosal dissection market can be deconstructed by examining product innovations across accessory devices and core endoscopy systems. Accessory devices encompass items such as cap and hood assemblies, forceps and clips, injection needles, insufflation units, various knife subtypes, and trocars. Within the knife category itself, dual, flex, hook, insulation-tipped, and triangle-tipped instruments delineate performance attributes tailored to specific tissue textures and lesion topographies. Endoscopy systems further subdivide into colonoscopes, duodenoscopes, and gastroscopes, each embodying unique ergonomic and optical configurations that influence procedural efficiency and clinician preference.

Procedural modalities range from full-thickness resection techniques that enable complete transmural excision to hybrid approaches that integrate submucosal tunneling with en bloc removal, as well as partial-thickness resections optimized for discrete lesions. These variants have demonstrated varying risk-benefit profiles, informing institutional adoption based on tumor characteristics and operator proficiency. Clinical indications driving ESD adoption include colorectal, esophageal, and gastric cancer, reflecting the epidemiological burden of early-stage neoplastic presentations. Parallel to indication-based segmentation is the classification by disease condition, distinguishing benign tumors from malignant tumors and further stratifying malignant cases into invasive and non-invasive categories. This granularity informs both technology utilization and outcome expectations.

Finally, end-user channels span ambulatory surgical centers, hospitals, and specialty clinics, each presenting distinct procedural volumes, reimbursement frameworks, and investment capacities. Ambulatory surgical centers are gaining traction as efficient venues for straightforward ESD procedures, while tertiary hospitals continue to anchor complex cases and training initiatives. Specialty clinics focused on advanced endoscopy further contribute to the diffusion of technique-specific expertise and high-acuity patient management.

Illuminating Regional Adoption Patterns, Reimbursement Frameworks, and Innovation Trajectories Across Global Markets

In the Americas, robust healthcare infrastructures and well-established reimbursement systems underpin a strong base for endoscopic submucosal dissection adoption. Centers of excellence across the United States and Canada lead in procedural volumes and publish pivotal clinical evidence, reinforcing stakeholder confidence. Policy environments that support advanced endoscopic interventions have enabled payers to recognize the long-term cost savings associated with minimally invasive lesion removal, thereby fostering patient access and institutional investment in cutting-edge devices.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and varying reimbursement pathways create a mosaic of adoption rates. Western European nations with centralized health technology assessment processes have integrated ESD into standard care protocols for indicated lesions, whereas emerging markets within the region are actively building clinical infrastructure and training networks to bridge gaps in procedural expertise. Meanwhile, several Middle Eastern health systems are accelerating capital investments in specialized endoscopy units to position their centers at the forefront of GI oncology treatment.

The Asia-Pacific region continues to be a global leader in procedural innovation and clinical evidence generation, driven by high patient volumes and proactive government initiatives. Countries such as Japan and South Korea remain pioneers in technique refinement, while rapidly developing economies like India and China are scaling training programs and local device manufacturing capacities. Collaborative research consortia and public-private partnerships in the region are further expediting technology transfer and establishing new benchmarks for affordability and access.

Competitive Landscape and Strategic Movements of Leading Stakeholders Shaping the ESD Ecosystem

A cadre of global medtech leaders and specialized innovators defines the competitive contours of the endoscopic submucosal dissection market. Established incumbents are reinforcing their portfolios through incremental product enhancements, securing intellectual property for advanced knife geometries and ergonomic scope designs, and leveraging global distribution networks to broaden market penetration. Simultaneously, agile startups are gaining traction by introducing AI-assisted lesion detection software and next-generation insufflation technologies aimed at streamlining procedural workflows.

Strategic partnerships and collaborations between device manufacturers, academic centers, and contract research organizations have accelerated clinical validation pathways and enhanced regulatory readiness. Moreover, mergers and acquisitions remain a focal strategy for integrating complementary technologies and fortifying intellectual property pipelines. As these developments unfold, leading stakeholders are also prioritizing lifecycle management programs that include reusable component sterilization solutions, subscription-based service models, and digital health platforms designed to monitor post-procedural outcomes.

Overall, the competitive landscape is characterized by a dual imperative: advancing clinical performance while optimizing total cost of ownership. Organizations that successfully align product innovation, service excellence, and data-driven customer support are best positioned to capture value in an increasingly sophisticated ESD environment.

Proactive Strategies and Collaborative Initiatives to Propel Innovation, Market Penetration, and Sustainable Growth

To capitalize on the burgeoning opportunities in endoscopic submucosal dissection, industry leaders must emphasize cross-functional partnerships that bridge clinical, regulatory, and commercial expertise. Prioritizing investment in R&D for next-generation electrosurgical knives with adaptive feedback mechanisms will differentiate product offerings and address evolving clinical challenges. Concurrently, establishing comprehensive training ecosystems that integrate virtual reality simulators and certified proctorship ensures consistent procedural quality and shortens adoption curves for emerging markets.

Engaging with payers and health authorities to demonstrate the value proposition of ESD through real-world evidence and cost-effectiveness analyses will facilitate favorable reimbursement decisions and expand patient access. Diversifying supply chain networks by incorporating regional manufacturing hubs and strategic sourcing initiatives can mitigate tariff-related risks while optimizing inventory turnover. Furthermore, developing digital platforms for perioperative patient engagement and outcome tracking will foster data-driven improvements in clinical protocols and strengthen long-term customer loyalty.

Ultimately, aligning these strategies with sustainable business models-such as service-based agreements and outcome-based reimbursement schemes-will enhance market resilience. By adopting a holistic approach that balances innovation, education, and stakeholder alignment, organizations can secure a leadership position in the evolving ESD ecosystem.

Rigorous Multimodal Research Framework Integrating Primary Inquiry, Secondary Data, and Analytical Triangulation

The research underpinning this executive summary was conducted through a meticulous blend of primary and secondary methodologies. Key opinion leaders and endoscopy specialists were engaged in structured interviews and advisory workshops to capture nuanced perspectives on clinical workflows, technology adoption barriers, and unmet needs in endoscopic submucosal dissection. These qualitative insights were complemented by an extensive review of peer-reviewed journals, clinical trial registries, and conference proceedings to validate evolving best practices and emergent device performance data.

Secondary research included systematic analysis of regulatory filings, patent landscapes, and financial disclosures to map innovation trajectories and competitive positioning. Additionally, a detailed assessment of tariff schedules, reimbursement codes, and health technology assessment reports informed the evaluation of macroeconomic drivers. Quantitative data points were then subjected to triangulation against real-world procedural volumes and market intelligence sources to ensure consistency and reliability. The final deliverables underwent multiple iterations of peer review and methodological audits to confirm the integrity of findings and recommendations.

Synthesis of Core Insights and Future Trajectories to Empower Decision Makers and Foster Market Leadership

This executive summary has elucidated the intricate interplay of technological innovation, regulatory shifts, and market dynamics shaping the endoscopic submucosal dissection domain. Key takeaways underscore the critical impact of advanced knife designs, enhanced imaging modalities, and AI-driven decision support tools on procedural efficacy and safety. Simultaneously, the ramifications of tariff adjustments and evolving reimbursement landscapes necessitate agile sourcing strategies and proactive stakeholder engagement.

Looking ahead, the maturation of competency-based training programs, cross-border collaborations, and localized manufacturing initiatives will accelerate diffusion in underpenetrated markets. The integration of digital health platforms for patient monitoring and outcome analytics promises to refine clinical protocols and bolster evidence generation. As industry leaders align on sustainable business models and engage payers with compelling value narratives, endoscopic submucosal dissection is poised to become a standardized cornerstone of early gastrointestinal cancer management. Decision makers equipped with these insights are well-positioned to navigate complexity, drive innovation, and deliver superior patient outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Expansion of water-jet and hybrid knife technologies for faster and safer lesion dissection in ESD
• 5.2. Adoption of artificial intelligence-driven lesion recognition systems in endoscopic submucosal dissection workflows
• 5.3. Development of multifunctional endoscopic knives enabling simultaneous incision and hemostasis during ESD procedures
• 5.4. Emergence of disposable endoscope platforms reducing cross-contamination risks in submucosal dissection treatments
• 5.5. Integration of high-definition 3D imaging and augmented reality overlays for precision in ESD lesion targeting
• 5.6. Growth of ESD training simulation programs employing virtual reality to accelerate physician proficiency in Asia-Pacific markets
• 5.7. Partnerships between medical device manufacturers and academic centers for clinical validation of novel traction devices for ESD
• 5.8. Regulatory approvals of next-generation endoscopic injection solutions enhancing submucosal lifting and procedural efficiency
• 5.9. Rising utilization of traction-assisted ESD techniques using clip-and-line systems to reduce procedure time and complications
• 5.10. Increase in reimbursement policies supporting outpatient endoscopic submucosal dissection procedures in developed healthcare systems

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Endoscopic Submucosal Dissection Market, by Product

• 8.1. Introduction
• 8.2. Accessory Devices
  • 8.2.1. Cap & Hood
  • 8.2.2. Forceps & Clips
  • 8.2.3. Injection Needles
  • 8.2.4. Insufflations Units
  • 8.2.5. Knives
    • 8.2.5.1. Dual
    • 8.2.5.2. Flex
    • 8.2.5.3. Hook
    • 8.2.5.4. Insulation-tipped
    • 8.2.5.5. Triangle-tipped
  • 8.2.6. Trocars
• 8.3. Endoscopy Devices
  • 8.3.1. Colonoscopes
  • 8.3.2. Duodenoscopes
  • 8.3.3. Gastroscopes

9. Endoscopic Submucosal Dissection Market, by Procedure Type

• 9.1. Introduction
• 9.2. Full-Thickness Resection
• 9.3. Hybrid ESD
• 9.4. Partial-Thickness Resection

10. Endoscopic Submucosal Dissection Market, by Indication Type

• 10.1. Introduction
• 10.2. Colorectal Cancer
• 10.3. Esophageal Cancer
• 10.4. Gastric Cancer

11. Endoscopic Submucosal Dissection Market, by Disease Condition

• 11.1. Introduction
• 11.2. Benign Tumors
• 11.3. Malignant Tumors
  • 11.3.1. Invasive
  • 11.3.2. Non-Invasive

12. Endoscopic Submucosal Dissection Market, by End-User Type

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Hospitals
• 12.4. Specialty Clinics

13. Americas Endoscopic Submucosal Dissection Market

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. Argentina

14. Europe, Middle East & Africa Endoscopic Submucosal Dissection Market

• 14.1. Introduction
• 14.2. United Kingdom
• 14.3. Germany
• 14.4. France
• 14.5. Russia
• 14.6. Italy
• 14.7. Spain
• 14.8. United Arab Emirates
• 14.9. Saudi Arabia
• 14.10. South Africa
• 14.11. Denmark
• 14.12. Netherlands
• 14.13. Qatar
• 14.14. Finland
• 14.15. Sweden
• 14.16. Nigeria
• 14.17. Egypt
• 14.18. Turkey
• 14.19. Israel
• 14.20. Norway
• 14.21. Poland
• 14.22. Switzerland

15. Asia-Pacific Endoscopic Submucosal Dissection Market

• 15.1. Introduction
• 15.2. China
• 15.3. India
• 15.4. Japan
• 15.5. Australia
• 15.6. South Korea
• 15.7. Indonesia
• 15.8. Thailand
• 15.9. Philippines
• 15.10. Malaysia
• 15.11. Singapore
• 15.12. Vietnam
• 15.13. Taiwan

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Ambu A/S
  • 16.3.2. Beijing ZKSK Technology Co., Ltd.
  • 16.3.3. Boston Scientific Corporation
  • 16.3.4. ConMed Corporation
  • 16.3.5. Erbe Elektromedizin GmbH
  • 16.3.6. Fujifilm Holdings Corporation
  • 16.3.7. Hoya Corporation
  • 16.3.8. Huger Medical Instrument Co., Ltd.
  • 16.3.9. Interscope, Inc.
  • 16.3.10. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • 16.3.11. Karl Storz SE & Co. KG
  • 16.3.12. Leo Medical Co. Ltd.
  • 16.3.13. Medi-Globe GmbH by DCC Healthcare
  • 16.3.14. Medtronic PLC
  • 16.3.15. Micro-Tech Endoscopy
  • 16.3.16. Mizuho America, Inc.
  • 16.3.17. MTW-Endoskopie W. Haag KG
  • 16.3.18. Olympus Corporation
  • 16.3.19. Ovesco Endoscope AG
  • 16.3.20. Richard Wolf GmbH
  • 16.3.21. SonoScape Medical Corp.
  • 16.3.22. Steris Corporation
  • 16.3.23. Zeon Medical Inc.
  • 16.3.24. Sumitomo Bakelite Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

• FIGURE 1. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 16. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 18. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 24. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 25. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHAI
• FIGURE 26. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHSTATISTICS
• FIGURE 27. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHCONTACTS
• FIGURE 28. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY REGION, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 71. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 73. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 75. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 77. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 79. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 81. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 83. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 85. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 86. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 87. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 88. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 89. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 90. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 91. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 92. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 93. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 94. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 95. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 96. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 97. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 98. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 99. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 100. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 101. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 102. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 103. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 105. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 106. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 107. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 108. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 109. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 110. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 111. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 112. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 113. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 114. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 115. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 116. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 117. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 118. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 119. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 120. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 121. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 122. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 123. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 124. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 125. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 126. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 127. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 128. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 129. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 130. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 131. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 132. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 133. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 134. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 135. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 136. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 137. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 138. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 139. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 140. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 141. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 142. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 143. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 144. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 145. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 146. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 147. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 148. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 149. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 150. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 151. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 152. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 153. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 154. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 155. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 156. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 157. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 158. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 159. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 160. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 161. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 162. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 163. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 164. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 165. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 166. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 167. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 168. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 169. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 170. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 171. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 172. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 173. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 174. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 175. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 176. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 177. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 178. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 179. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 180. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 181. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 182. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 183. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 184. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 185. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 186. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 187. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 188. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 189. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 190. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 191. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 192. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 193. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 194. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 195. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 196. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 217. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 218. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 219. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 220. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 221. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 222. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 223. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 224. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 225. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 226. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 228. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 230. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 232. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 234. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 235. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 236. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 237. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 238. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 239. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 240. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 241. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 242. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 243. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 244. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 245. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 246. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 247. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 248. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 249. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 250. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 251. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 252. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 253. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 254. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 255. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 256. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 257. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 258. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 259. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 260. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 261. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 262. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 263. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 264. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 265. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 266. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 267. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 268. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 269. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 270. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 271. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 272. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 273. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 274. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 275. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 276. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 277. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 278. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 279. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 280. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 281. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
• TABLE 282. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
• TABLE 283. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
• TABLE 284. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
• TABLE 285. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
• TABLE 286. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
• TABLE 287. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
• TABLE 288. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
• TABLE 289. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 290. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
• TABLE 291. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 292. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 293. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
• TABLE 294. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
• TABLE 295. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
• TABLE 296. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
• TABLE 297. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET